Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TRIUS THERAPEUTICS
(NQ:
TSRX
)
8.630
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
8.670
Bid (Size)
8.000 (500)
Ask (Size)
9.500 (100)
Prev. Close
8.630
Today's Range
8.510 - 8.690
52wk Range
4.410 - 9.250
Shares Outstanding
47,872,124
Dividend Yield
N/A
Top News
More News
Lightning Round: MGM, AMD and More
June 18, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Read More
category
MGM MIRAGE
,
Advanced Micro Devices Inc
,
Loews Corp/
, and 9 more.
from
CNBC.com News
Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics
June 18, 2013
Editor Note: For more information about this release, please scroll to bottom.
Read More
from
PR Newswire
More News
Read More
7 Biotechnology Stocks to Sell Now
June 12, 2013
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Trius Therapeutics Announces Publication of Antibiotic Safety Study in Antimicrobial Agents and Chemotherapy
June 12, 2013
from
GlobeNewswire News Releases
New Studies, Regulatory Submissions, and Leadership Changes - Research Report on St. Jude Medical, Teva Pharmaceutical Industries, Avanir Pharmaceuticals, Novo Nordisk, and Trius Therapeutics
June 10, 2013
from
PR Newswire
Commit To Buy Trius Therapeutics At $5, Earn 11.1% Annualized
June 06, 2013
category
Stocks
from
Market News Video
Commit To Buy Trius Therapeutics At $5, Earn 11.1% Annualized
June 06, 2013
category
Dividends
from
Dividend Channel
A Simple Quant Screen That Looks For A Few Bearish Stock Picks
June 05, 2013
category
NASDAQ:CBST
,
NASDAQ:TSRX
from
Forbes Real Time
7 Biotechnology Stocks to Sell Now
June 05, 2013
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Will Trius Be The Next Big Small-Cap Biotech Mover?
June 04, 2013
category
Pharmaceuticals
from
Trefis
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.